Kumar Muthalagappan Obe

Kumar Muthalagappan OBE is an accomplished professional with extensive experience in leadership roles across various sectors, particularly in healthcare and research. Currently serving as Senior Independent Director at ObjectiveHealth and an advisor at Vitruvian Partners, Kumar has previously held prominent positions such as CEO and Chairman of Oncacare, where efforts were focused on enhancing cancer research and trial accessibility. Kumar's tenure as CEO of MeDiNova Research resulted in the company's acquisition by ICON plc after substantial growth and patient recruitment success. Additional achievements include significant board memberships and leadership roles with the Olympic Delivery Authority, City of Birmingham Symphony Orchestra, and various committees for organizations like VisitBritain and Alexandra Palace. Educational credentials include being a Fellow of The Institute of Chartered Accountants in England and Wales and a Bachelor’s degree in Accounting & Financial Analysis from the University of Warwick.